U.S. Markets open in 8 hrs 24 mins

US Equity Holdings Expands Interest in Biotechnology

US Equity Holdings Expands Interest in Biotechnology Click here for high-resolution version

SAN FRANCISCO, CA--(Marketwired - May 15, 2015) - Building on its recent formation of Mount Tam Biotechnologies, US Equity Holdings is actively expanding its interest in biotechnology and will shortly announce its next significant venture. US Equity Holdings establishes and supports high-growth organizations by creating or licensing valuable intellectual property, forming strong management teams and financing its initiatives to successful exits.

The US Equity Holdings team has been assessing several promising technologies and has secured funding for a new biotechnology startup that will join Mount Tam Biotechnologies among a growing number of biotechnology companies in the US Equity Holdings portfolio. US Equity Holdings Chairman and CEO Chester Aldridge has more than 20 years of experience in founding, operating and financing businesses, ranging from startups to multi-million-dollar publicly traded companies.

"This is a unique time with interesting business opportunities in biotechnology and biomedicine," said Aldridge, who has recently been focusing on pharmaceutical and biomedical ventures with an interest in health extension. Biopharmaceutical company Mount Tam Biotechnologies was recently established to develop, optimize and bring to market a number of drug candidates to improve the health and well-being of millions of people who have been affected by autoimmune diseases. Mount Tam's most advanced product focuses on the treatment of systemic lupus erythematosus (SLE), the most common form of lupus.

By working with scientists from research institutes and universities around the globe, US Equity Holdings recognizes that it can help to provide the benefits not only of an innovation-focused culture, but also of stable, long-term financing, better opportunities to benchmark the value of R&D and streamlined access to critical regulatory and marketing skills.

"Modern-day biotech startups require not only great R&D but also critical business support," said Aldridge. "Our goal is not simply to secure funds to support research, but to identify one or more private sector partners for each innovation we incubate. We provide the business and financial infrastructure for the early-stage development of innovative products, treatments and technologies."

About US Equity Holdings

US Equity Holdings establishes and supports high-growth organizations by creating or licensing valuable intellectual property, forming strong management teams and financing its initiatives to successful exits.

The company provides a number of advisory services for individuals and companies ranging from startups to large publicly traded corporations. Its areas of expertise include licensing, strategic planning and analysis, business development, merchant banking, venture capital and investment banking. US Equity Holdings has led ventures in multiple industries, from entertainment and technology to renewable energy and biotechnology. 

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2823677